Your browser doesn't support javascript.
loading
Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma.
Hussaarts, Koen G A M; van Doorn, Leni; Bins, Sander; Sprengers, Dave; de Bruijn, Peter; van Leeuwen, Roelof W F; Koolen, Stijn L W; van Gelder, Teun; Mathijssen, Ron H J.
Afiliação
  • Hussaarts KGAM; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
  • van Doorn L; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
  • Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
  • Sprengers D; Department of Hepatology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
  • de Bruijn P; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
  • van Leeuwen RWF; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
  • Koolen SLW; Department of Hospital Pharmacy, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
  • van Gelder T; Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
  • Mathijssen RHJ; Department of Hospital Pharmacy, Erasmus MC Cancer Institute, 3015 CN Rotterdam, The Netherlands.
Pharmaceuticals (Basel) ; 14(1)2021 Jan 09.
Article em En | MEDLINE | ID: mdl-33435321

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article